Abstract: The present invention relates to modulators of the interaction between G-protein coupled receptor 15(GPR15) and c10orf99. The modulator may be a small chemical molecule, antibody or other therapeutic protein. Methods of medical treatment and methods of identifying modulators are also described.
Type:
Grant
Filed:
October 23, 2014
Date of Patent:
February 12, 2019
Assignees:
Novartis AG, Odega S.A.
Inventors:
Frederic Bassilana, Birgit Uta Baumgarten, Nathalie Marie-Therese Carte, Michel Detheux, Rocco Falchetto, Sebastien Hannedouche, Vincent Lannoy, Keith Mansfield, Klaus Peter Seuwen, Thomas Laurent Henri Suply